COVID-19
Conditions
Interventions
control group:Regular treatment
Sponsors
Shanghai Children‘s Medical Center
Eligibility
Sex/Gender
All
Age
3 Years to 18 Years
Inclusion criteria
Inclusion criteria: 1. Patients with mild Covid-19 infection aged 3-18 years old (in line with the diagnostic criteria of the Diagnosis and Treatment Program for Novel Coronavirus Pneumonia (Trial Ninth Edition)); Covid-19 nucleic acid PCR test is positive, regardless of sex; 2. With symptoms of cough and expectoration; 3. The course of disease is within 5 days; 4. Have not used traditional Chinese medicine or Chinese patent medicine preparations with similar functions to this prescription within 24 hours before joining the group; 5. Agree to sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1. It is not guaranteed to take medicine during the observation period of this study; 2. Those who have major basic diseases, or chronic basic diseases in the acute stage, or need long-term oral or injection drugs; 3. History of severe allergic reactions to ingredients in Huashi Baidu granule; 4. Taking other Chinese patent medicines or traditional Chinese medicines during the screening period and research period; 5. Participants in other COVID-19 related clinical trials; 6. Patients and guardians are unable to cooperate to complete the study and follow-up.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Negative time of nucleic acid; | — |
Secondary
| Measure | Time frame |
|---|---|
| Improvement of TCM symptoms and signs; | — |
Countries
China
Contacts
Public ContactGao Jian
Shanghai Children‘s Medical Center
Outcome results
None listed